Magdalena Cubala-Kucharska

dr Magdalena Cubala-KucharskaThe founder of Arcana Institute of Integrational Medicine.
Medical Doctor, with over 20-year experience in family medicine and functional medicine. Her main field of interest - medical problems of autistic children, underlying and complicating the severity of autism.
She took part in numerous trainings in the field of autism in Europe and the USA. Also, she was a speaker at numerous conferences in Poland and Europe. Since 2004 she has been a member of Defeat Autism Now!. Her experience in the field includes work as specialist in autism at Breakspear Medical Hospital in the UK and at Autism Treatment Trust, Edinburgh. She participates in numerous research projects in the field of autism, and she initiated her own research in this subject. Currently, she is focused on the detoxification processes in the liver. Also, in connection with the Medical University of Lodz she is researching the connection between food allergy and food intolerance and autism.
Before taking interest in autism, she was a leader of natural medicine in Poland. Also, she worked for WHO and Polish Ministry of Health.

Dr Nicola Antonucci

Dr AntucciMD from University of Bari, Italy in July 2000. Specialized in the same University in Psichiatry in January 2005. During the School of Specialization he was member of research of “Gruppo di Neuroscienze Psichiatriche” and worked on NeuroImaging Field using functional MRI and Spectroscopy  applied in patients affected by schizofrenia. Since October 2006, when his daughter was diagnosed ASD, he started to work with Biomedical Treatment of ASDs using the knowledge of Autism Research Institute – San Diego (CA). He followed medical training  for several months at the “The Rimland Centre – Lynchburg (VA)” under the mentoring of Dr E. Mumper. He is still attending annual scientific meeting and training of Autism Research Institute. He is now director of the “Biomedical Centre for Autism Research and Treatment” in Bari - Italy and working in several towns of Italy, as well as in several Countries exclusively with children affected by ASDs. In 2010, in collaboration with Dr. Dario Siniscalco, Second University of Naples, he founded a research group to study molecular and cellular changes in ASDs. This group is conducting several research trials and has already published some works on international peer-reviewed journals in the field of Autism. He wil give a lecture on:
Heavy Metal Toxicity in Autism: review of risk factors, biomarkers and treaments.

An increase in number of  scientific researches are suggesting that Autism Spectrum Disorder can be related to metabolic encephalopathy by accumulating heavy metals in the body tissues of the effected children. The report will show the recent published international studies about risk factors and possible causes of this intoxication.  Also it will discuss how to diagnose this clinical condition and which detoxifying  and chelation treatments to date have been used most effectively with children diagnosed within the Autistic Spectrum Disorder.

Corinne Skorupka MD

Corinne Skorupka

President of the Association Ariane

Doctor Corinne Skorupka is a psychiatrist who was trained in the “Defeat Autism Now” protocol. She is the president of the Ariane Association, the only French partner of the Autism Research Institute. Ariane Association's goal is to give you the right way that will allow you to find again hope to fight the most unknown 21st century diseases. Autism, Pervasive Developmental Disorders, syndrome of chronic fatigue and Lyme disease represent all the multifactorial genetic, nutritional and environmental axis of its approach. The role of environment in emergence of autism was confirmed every year, but her encounter with Professor Luc Montagnier, Nobel Laureate of medicine in 2008, was determinente to discover the missing piece of the puzzle of autism. A study, financed by the Autism Research Institute and led by Professor Luc Montagnier has confirmed the infectious track of autism. She has treated more than 2000 autistic children in Europe, Morocco and  Tunisia and she is currently involved since 2010 in a working group called “chronimed” at “UNESCO”

The subject of Corinne Skorupka lecture will be:Autism:the microbial track. 

The spectacular growth of developmental disorders, as well as the growing number of children who regress after an initially “normal” development” can’t be explained simply in terms of more efficient diagnosis or even by the widening of the criteria of diagnosis. Neither can it be explained by the idea of a genetic “epidemic”. On the other hand, we must consider environmental factors, as they have changed considerably our biosphere : infant nutrition, air pollution and pesticides, increased exposure to electromagnetic radiation of all frequencies associated with the globalization of human communication, and change of our microbial flora. We find in the blood of most autistic children - but not in healthy children -DNA sequences that emit, in certain conditions, electromagnetic waves. The analysis by molecular biology techniques allows us to identify these electromagnetic waves as coming from already known bacterial species.
 This correlation, based on more than two hundred children of European origin, reinforces the idea that systemic bacterial infections play a role in the genesis of symptoms of autism.We observed that a long-term therapy consisting of successive antibiotic treatments with accompanying biomedical treatment induced a significant improvement, sometimes even a complete resolution of symptoms. The working hypothesis is that immune dysfunction associated with inflammation of the intestinal mucosa leads to the introduction of bacterial components, including neurotoxins,
into the bloodstream, creating oxidative stress as well as microvascularities, especially affecting meningeal vessels, and finally specific neuronal damage.

Prof. Kenny De Meirleir

Kenny De MeirleirProfessor Dr. Kenny de Meirleir(KDM) is a full-time professor of internal medicine at the Vrije Universiteit Brussel in Belgium. He is a well published researcher, a search on "De Meirleir K[Author]"[1] at PubMed yields 85 publications, many of which concern ME/CFS.

He sees and treats ME/CFS patients in his clinic in Belgium, but also regularly travels abroad, currently to Norway, Sweden and Australia, to care for patients. Outside Belgium, he is an accredited specialist in internal medicin/internist in Norway and Sweden.

Dario Siniscalco, ChemD, PhD

DarioDepartment of Experimental Medicine, Second University of Naples, Italy

Centre for Autism – La Forza del Silenzio, Caserta, Italy

Cancellautismo – no profit association for autism care, Florence, Italy.

Dr. Dario Siniscalco is Research Associate for the Department of Experimental Medicine of the Second University of Naples (SUN), Italy.  He graduated in Chemistry from the University of Naples “Federico II” in 2000 and received his Ph.D. in Pharmacological Sciences from SUN in 2004. He completed his neuropathology fellowship at University of Alabama at Birmingham, USA before joining the Second University of Naples staff in 2006. He is registered member of the following scientific societies: Order of the Chemists of Campania, National Council for Chemistry, Stem Cell Research Italy, European Association for Chemical and Molecular Sciences, Italian Pharmacological Society, Cell Death Research Group - University of Alabama at Birmingham, USA. Author or co-author of 38 scientific peer-reviewed papers and 7 book chapters. Presented his work to 92 national and international conferences. He is serving as an editorial board member of reputed journals and reviewer of more than 25 journals. His main research interests: gene expression and molecular regulation in autism spectrum disorders; use of human mesenchymal stem cells as therapeutic tool in autism. Other research interests: stem cells therapy for the neuronal recovery; studying of neuronal apoptosis. Role of  bcl-2 family, caspases, and cell cycle regulator genes. The subject of Dr Siniscalco's lecture will be: Stem cell therapy for autism spectrum disorders

Autism spectrum disorders (ASDs) are heterogenous neurodevelopmental pathologies characterized by impairments in social interaction and communication and by restricted, repetitive, and stereotyped patterns of behaviour. Commonly, the symptoms are apparent before the 3 age of years. ASDs have been recognized as public health problem. Prevalence rate of ASDs is fast increasing. The lack of specific biologic markers for diagnosis provides challenges in monitoring the prevalence of ASDs. There are currently no approved treatments for ASD core symptoms. Pharmacological intervention does not affect all core symptoms, providing partial relief for some dysfunctional behaviour. Current available strategies for ASDs can be divided into behavioural, nutritional, and drug therapy. Stem cell therapy represents the great promise for the future of molecular and regenerative medicine. Several types of stem cells offer a valid approach to curing several untreatable human neurodegenerative diseases. Recent advances in ASD molecular mechanisms indicate that stem cell therapy could be a potent treatment for autistic syndromes.

Raymond Theodorus Berend Pahlplatz MD

Medical University Maastricht (MD)

Employee in the International Biomedical Center in Leende, the Netherlands

Orthomolecular medicine; Chelation-physician (IBCMT); Board member IBCMT.com; Treasurer of IBCMT

Presentations, lectures, teaching in the Netherlands, Germany, Belgium, Taiwan, South-Africa, Spain regarding:  “An Approach to treating Cancer”; “Parkinson’s Disease and other neurodegenerative diseases”;“Arterial Stiffness”; “Why are Metals Toxic?”;New insights into Diabetes”

And many more on behalf of IBCMT.com

2005 Article “Lactoferrin” in Ortho® nr. 5-2005 (dutch)

2010 Article “Insulinresistenz” in german orthomolecular magazine “OM & Ernährung” nr. 132

Title of presentation: Mitochondrial influence in autism

Like in most degenerative diseases the mitochondrion has a pivotal role in autism as well. By analyzing the molecular fundamentals of mitochondria we have learnt how to regulate and influence their behavior in order to stop their excessive production of reactive oxygen species. Relatively new substances like Pyrroloquinoline Quinone (PQQ) can strongly enhance mitochondrial function. This and other ingredients can enhance our treatment plans for this but also other neurodegenerative diseases.
Get Adobe Flash player


  • If You would like to take part in Conference You need to register.
  • REGISTER >>>

Our Speakers

  • Dr. Nicola Antonucci-  Italy
  • Professor Krzysztof Buczyłko,Poland
  • Dario Siniscalco PhD
  • Dr.Magdalena Cubała- Kucharska, Poland
  • Dr. Raymond Pahlplatz, Netherlands
  • Justyna Leszka,PhD, Polska
  • Professor Kenny De Meirler, Belgia
  • Dr Corinne Skorupka, France
  • Anna Skrzecz, Poland
  • Anna Rozetti-Szymańska PhD, Poland
  • Agnieszka Sulich, Poland
  • i wielu innych

Contact us



Mobile +48 501756971

Conference will take place in:

Institute of National Health

ul. Chocimska 24,
00-791 Warszawa

NIZP - PZH w google maps